Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective correlation factors for dengue: natural infection versus Qdenga vaccination across age groups
RBR-7k3nv44Phase 2Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of dengue tetravalent vaccine, live, attenuated in dengue fever (2 cohorts), sponsored by Universidade Federal de Minas Gerais. Started Nov 2023; status: completed.
02
Drugs
dengue tetravalent vaccine, live, attenuated
03
Conditions
dengue fever
Beyond the preview
Go deeper on RBR-7k3nv44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7k3nv44.